Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
The trial tested oral AOD-9604 at doses ranging from 0.25 mg to 9 mg per day
in laboratory mouse models of colitis suggested that ARA-290 peptide appeared to exhibit apparent interactions including enhanced tissue quality and reduced disease progression in these settings, with researchers proposing the peptide may have bound with IRR receptor cells and yielded anti-inflammatory interactions in these models
Its structure was confirmed by mass spectrometry and amino acid analysis [2]
If your order has been pending or not shipped for a few days you may email us at [email protected]
This content should not be used as a substitute for consultation with a qualified, licensed physician
US$ 28.16
US$ 26.27
US$ 21.54
